HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Chunghyuldan

has been used as an antihyperlipidemic and antiischemic agent in Korea; CHD showed antioxidant activities in vitro, and inhibited nitric oxide (NO) and prostaglandin E2 (PGE2) productions in lipopolysaccharide (LPS)-induced RAW264.7 cells
Networked: 7 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Cho, Ki-Ho: 4 articles (12/2013 - 12/2005)
2. Kim, Hyo Geun: 3 articles (06/2014 - 12/2010)
3. Oh, Myung Sook: 3 articles (06/2014 - 12/2010)
4. Jung, Woo-Sang: 3 articles (12/2013 - 12/2005)
5. Lee, Eunjoo H: 3 articles (09/2011 - 06/2009)
6. Park, Seong-Uk: 2 articles (12/2013 - 12/2005)
7. Moon, Sang-Kwan: 2 articles (12/2013 - 12/2005)
8. Kang, Chulhun: 2 articles (12/2013 - 06/2009)
9. Ko, Chang-Nam: 2 articles (12/2013 - 12/2005)
10. Kim, Sun Yeou: 2 articles (09/2011 - 12/2010)

Related Diseases

1. Stroke (Strokes)
2. Parkinson Disease (Parkinson's Disease)
3. Memory Disorders (Memory Loss)
4. Neuroblastoma
5. Ischemia

Related Drugs and Biologics

1. Oxazolone
2. glucuronyl glucosamine glycan sulfate (Vessel)